Literature DB >> 26323214

Patients' attitudes to risk in lung cancer surgery: A qualitative study.

H A Powell1, L L Jones2, D R Baldwin3, J P Duffy4, R B Hubbard5, A M Tod6, L J Tata5, J Solomon7, M Bains5.   

Abstract

OBJECTIVES: Lung cancer surgery leads to long term survival for some patients but little is known about how patients decide whether to accept the associated surgical risks. The objective of this qualitative study was to explore patients' attitudes to the risks associated with lung cancer surgery.
METHODS: Fifteen patients with resectable lung cancer, recruited via multi-disciplinary team meetings at an English tertiary referral centre, participated in semi-structured interviews to explore their attitudes to the morbidity and mortality risks associated with lung cancer surgery. Transcripts were analysed using the framework method.
RESULTS: Participants reported being 'pleased' to hear that they were suitable for surgery and felt that surgery was not a treatment to be turned down because they did not see any alternatives. Participants had some knowledge of perioperative risks, including mortality estimates; however, many voiced a preference not to know these risks and to let the medical team decide their treatment plan. Some found it difficult to relate the potential risks and complications of surgery to their own situation and appeared willing to accept high perioperative mortality risks. Generally, participants were willing to accept quite severe long-term postoperative breathlessness; however, it was apparent that many actually found this possibility difficult to imagine.
CONCLUSION: Patients do not necessarily wish to know details of risks associated with lung cancer surgery and may wish to defer decisions about treatment to their medical team. Investment in the doctor-patient relationship, particularly for the surgeon, is therefore important in the management of patients with lung cancer.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Lung neoplasm; Morbidity; Mortality; Qualitative Research; Risk; Thoracic surgery

Mesh:

Year:  2015        PMID: 26323214     DOI: 10.1016/j.lungcan.2015.08.014

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  4 in total

1.  Ethical challenges in conducting clinical research in lung cancer.

Authors:  Peter Allmark; Angela M Tod
Journal:  Transl Lung Cancer Res       Date:  2016-06

2.  Treatment recommendations for stage I non-small cell lung cancer: does patient preference matter?

Authors:  Helen A Powell; David R Baldwin
Journal:  Ann Transl Med       Date:  2017-10

3.  The Value of Hope: Patients' and Physicians' Preferences for Survival in Advanced Non-Small Cell Lung Cancer.

Authors:  Brett Hauber; John R Penrod; David Gebben; Lina Musallam
Journal:  Patient Prefer Adherence       Date:  2020-10-30       Impact factor: 2.711

4.  Curing Operable Stage I Non-Small Cell Lung Cancer With Stereotactic Ablative Body Radiotherapy: The Force Awakens.

Authors:  Shankar Siva; David Ball
Journal:  Oncologist       Date:  2016-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.